SCHEMBL30879282

SCHEMBL30879282

CC(C)[Si](C#Cc1c(-c2cccc(F)c2Cl)c(=O)n(C)c2nc(Nc3ccc(N(C)CCN(C)C)cc3)ncc12)(C(C)C)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 7/20 0.42
WEE1 P30291 10/20 0.41
CCNT1 O60563 2/20 0.40
CDK9 P50750 2/20 0.40
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
SRC P12931 5/20 0.40
EGFR P00533 3/20 0.40
PDGFRB P09619 3/20 0.40
PDGFRA P16234 3/20 0.40
ABL1 P00519 2/20 0.40
MAPK14 Q16539 2/20 0.40
KIT P10721 1/20 0.40
FGFR4 P22455 1/20 0.39
KCNH2 Q12809 1/20 0.39
STAT5A P42229 1/20 0.38
ACVR1 Q04771 1/20 0.38
PKMYT1 Q99640 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879233 0.90 WEE1 (0.52) FGFR1WEE1CCNT1CDK9CDK4
SCHEMBL30878365 0.89 FGFR1 (0.47) FGFR1WEE1CCNT1CDK9CDK4
SCHEMBL30879066 0.89 FGFR1 (0.48) FGFR1WEE1CCNT1CDK9CDK4
SCHEMBL30878874 0.88 FGFR1 (0.43) FGFR1WEE1CCNT1CDK9CDK4
SCHEMBL30879118 0.86 WEE1 (0.42) FGFR1WEE1CCNT1CDK9CDK4
SCHEMBL30878690 0.86 FGFR4 (0.43) FGFR1WEE1CCNT1CDK9CDK4
SCHEMBL30879105 0.84 FGFR1 (0.46) FGFR1WEE1CCNT1CDK9CDK4
SCHEMBL30879314 0.82 CCNT1 (0.44) FGFR1WEE1CCNT1CDK9CDK4
SCHEMBL30878665 0.80 WEE1 (0.49) FGFR1WEE1SRCEGFRPDGFRB
SCHEMBL30879194 0.80 WEE1 (0.62) FGFR1WEE1CDK4CCND1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed